Cost‐effectiveness of temperature monitoring to help prevent foot ulcer recurrence in people with diabetes: A multicenter randomized controlled trial
Kosteneffektivität der Temperaturüberwachung zur Vorbeugung eines erneuten Fußulkus bei Menschen mit Diabetes: multizentrische randomisierte kontrollierte Studie
Diabetes/Metabolism Research and Reviews · 2024-05 · 40 (4)
DOI: 10.1002/dmrr.3805 ↗Auf einen Blick
Bei 304 Hochrisikopersonen war die häusliche Hauttemperaturüberwachung mit niedrigeren Fußversorgungskosten verbunden, aber auch mit geringeren QALYs. Die Kosteneffektivität war daher höchstens gleichwertig.
Fragestellung
Ist die tägliche häusliche Hauttemperaturüberwachung zusätzlich zur üblichen Fußpflege bei Menschen mit Diabetes hochrisikorelevant kosteneffektiv zur Vorbeugung eines erneuten Fußulkus?
Methode
Multizentrische randomisierte kontrollierte Studie mit 304 Personen; Vergleich von üblicher Fußpflege plus täglicher häuslicher Fußhaut-Temperaturüberwachung versus üblicher Pflege allein; Follow-up 18 Monate.
Ergebnisse
Die Intervention hatte eine 45 %ige Wahrscheinlichkeit, bei €50.000 pro QALY-Verlust kosteneffektiv zu sein. Kosten: €6067 vs. €7376; p = 0,45. Ulkusrezidive: 36 % vs. 47 %; p = 0,045. QALYs: 1,09 vs. 1,12; p = 0,35.
Schlussfolgerung der Autor:innen
Die häusliche Hauttemperaturüberwachung zur Vorbeugung diabetesbedingter Fußulkus war im Vergleich zur üblichen Versorgung höchstens gleich kosteneffektiv. Die Einsparungen gingen mit QALY-Verlusten einher.
Kernaussagen
- 45 % Wahrscheinlichkeit für Kosteneffektivität bei €50.000 pro QALY-Verlust
- Weniger Ulkusrezidive: 36 % vs. 47 %
- Niedrigere Kosten, aber auch geringere QALYs
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 30.04.2024. Verfasst von Jaap J Van Netten und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Diabetic Foot, Quality-Adjusted Life Years. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Netherlands Organization for Health Research and Development, Dutch Society for Podiatrists, Dutch Branch Organization for Pedicures.
Themen: Diabetisches Fußsyndrom, Diabetes mellitus
Abstract (Originalsprache)
Aims
Diabetes‐related foot ulcers are common, costly, and frequently recur. Multiple interventions help prevent these ulcers. However, none of these have been prospectively investigated for cost‐effectiveness. Our aim was to evaluate the cost‐effectiveness of at‐home skin temperature monitoring to help prevent diabetes‐related foot ulcer recurrence. Materials and Methods Multicenter randomized controlled trial. We randomized 304 persons at high diabetes‐related foot ulcer risk to either usual foot care plus daily at‐home foot skin temperature monitoring (intervention) or usual care alone (control). Primary outcome was cost‐effectiveness based on foot care costs and quality‐adjusted life years (QALY) during 18 months follow‐up. Foot care costs included costs for ulcer prevention (e.g., footwear, podiatry) and for ulcer treatment when required (e.g., consultation, hospitalisation, amputation). Incremental cost‐effectiveness ratios were calculated for intervention versus usual care using probabilistic sensitivity analysis for willingness‐to‐pay/accept levels up to €100,000.
Results
The intervention had a 45% probability of being cost‐effective at a willingness‐to‐accept of €50,000 per QALY lost. This resulted from (non‐significantly) lower foot care costs in the intervention group (€6067 vs. €7376; p = 0.45) because of (significantly) fewer participants with ulcer recurrence(s) in 18 months (36% vs. 47%; p = 0.045); however, QALYs were (non‐significantly) lower in the intervention group (1.09 vs. 1.12; p = 0.35), especially in those without foot ulcer recurrence (1.09 vs. 1.17; p = 0.10).
Conclusions
At‐home skin temperature monitoring for diabetes‐related foot ulcer prevention compared with usual care is at best equally cost‐effective. The intervention resulted in cost‐savings due to preventing foot ulcer recurrence and related costs, but this came at the expense of QALY loss, potentially from self‐monitoring burdens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Movement Sciences, Program Rehabilitation, Amsterdam, the Netherlands.
- Department of Surgery, Hospital Group Twente, Almelo, the Netherlands.
- Department of Epidemiology and Data Science, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Public Health, Amsterdam, the Netherlands.
ORCID-Profile: Jaap J Van Netten
Förderung
- Netherlands Organization for Health Research and Development
- Dutch Society for Podiatrists
- Dutch Branch Organization for Pedicures
- ZonMw
Zitieren
APA
Van Netten, J. J., Aan De Stegge, W. B., Dijkgraaf, M. G. W., & Bus, S. A. (2024). Cost‐effectiveness of temperature monitoring to help prevent foot ulcer recurrence in people with diabetes: A multicenter randomized controlled trial. Diabetes/Metabolism Research and Reviews, 40(4). https://doi.org/10.1002/dmrr.3805
Vancouver
Van Netten JJ, Aan De Stegge WB, Dijkgraaf MGW, Bus SA. Cost‐effectiveness of temperature monitoring to help prevent foot ulcer recurrence in people with diabetes: A multicenter randomized controlled trial. Diabetes/Metabolism Research and Reviews. 2024;40(4). doi:10.1002/dmrr.3805
BibTeX
@article{VanNetten2024,
author = {Van Netten, Jaap J and Aan De Stegge, Wouter B and Dijkgraaf, Marcel G W and Bus, Sicco A},
title = {Cost‐effectiveness of temperature monitoring to help prevent foot ulcer recurrence in people with diabetes: A multicenter randomized controlled trial},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2024},
volume = {40},
number = {4},
doi = {10.1002/dmrr.3805}
}
EUVIMED